Expanding Veterans’ Access to Emerging Treatments Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 4
- Latest action
- Feb 2, 2026
What it does
The bill directs the Secretary of Veterans Affairs to establish an investigational research and extended access program within 90 days of enactment to study and provide access to innovative treatments—including psychedelic and entactogenic therapies like psilocybin, ketamine, and ibogaine—for veterans with conditions such as PTSD, chronic pain, depression, anxiety, substance use disorders, and traumatic brain injury. The program will allow veterans to participate in clinical trials or receive compassionate use of these therapies under a defined process, with a required one-year report on findings and a two-year sunset review. The Secretary may designate additional treatments and conditions,…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.